IN8BIO INC's ticker is and the CUSIP is 45674E109. A total of 22 filers reported holding IN8BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $352,277 | -20.5% | 338,728 | +17.8% | 0.00% | – |
| Q2 2023 | $442,853 | +62.2% | 287,567 | +36.9% | 0.00% | – |
| Q1 2023 | $273,091 | -29.9% | 210,070 | +24.6% | 0.00% | – |
| Q4 2022 | $389,595 | +13.9% | 168,656 | -0.5% | 0.00% | – |
| Q3 2022 | $342,000 | +36.8% | 169,528 | +53.1% | 0.00% | – |
| Q2 2022 | $250,000 | -32.8% | 110,695 | -0.7% | 0.00% | – |
| Q1 2022 | $372,000 | -29.5% | 111,493 | -7.3% | 0.00% | – |
| Q4 2021 | $528,000 | -31.9% | 120,216 | +6.3% | 0.00% | – |
| Q3 2021 | $775,000 | – | 113,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Voss Capital, LLC | 101,779 | $446,000 | 0.14% |
| B. Riley Financial, Inc. | 257,378 | $1,130,000 | 0.13% |
| Nantahala Capital Management | 373,169 | $1,638,000 | 0.06% |
| Sigma Planning Corp | 28,600 | $126,000 | 0.00% |
| Ensign Peak Advisors, Inc | 70,028 | $307,000 | 0.00% |
| Capital World Investors | 800,000 | $3,512,000 | 0.00% |
| MORGAN STANLEY | 1,928 | $8,000 | 0.00% |
| BlackRock Inc. | 9,561 | $42,000 | 0.00% |
| HighTower Advisors, LLC | 10,000 | $44,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,176 | $14,000 | 0.00% |